News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-19 8:55:22 am Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million BusinessWire
2024-03-18 4:30:0 am Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas Business Wire
2024-03-15 4:30:0 am Cybin Initiates Phase 2 Proof-of-Concept Study of CYB004 in Generalized Anxiety Disorder Business Wire
2024-03-14 4:30:0 am Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design Business Wire
2024-03-13 4:0:0 am Announces Oversubscribed Private Placement of U.S. $150 Million Business Wire
2024-03-13 3:0:0 am Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and Announces Positive Four-Month Durability Data in Major Depressive Disorder Business Wire
2024-03-12 7:37:0 pm Cybin to Host Conference Call and Webcast to Provide Program Update for CYB003 Business Wire
2024-02-27 4:30:0 am Cybin to Present at the TD Cowen 44th Annual Health Care Conference Business Wire
2024-02-14 4:45:0 am Cybin Reports Third Quarter Financial Results and Recent Business Highlights Business Wire
   

Please consider a small donation if you think this website provides you with relevant information